Viral Vectors Market for Cell Therapy Market: Analysis and Opportunities

    Published: December 20, 2021 | Price: $3,000.00 – $6,000.00

    Viral vectors are useful tools used by molecular biologists to delivery genetic material into cells. Kalorama Information’s Viral Vectors Market Analysis and Opportunities reveals that viral vectors comprise a rising market that is expected to continue to grow as usage increases and novel technologies enter the market. Viral vectors are the most effective means of gene transfer to modify specific cells or alter the expression of therapeutic genes. The choice of viral vector depends on the efficiency of transgene expression,...
    In Vitro Diagnostics (IVD) Market in China, 2021

    Published: September 29, 2021 | Price: $4,000.00 – $8,000.00

    As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. China as an IVD market opportunity is defined by its standing next to other populous countries with demonstrated economic promise for over...
    The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, AutoImmune, Others)

    Published: March 23, 2021 | Price: $5,000.00 – $10,000.00

    Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. This report focuses on diagnostics.  The World Market for Biomarkers estimates the world markets for biomarkers and biomarker tests from 2015 to 2024,...